Position in SNY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$18,719,718
+$6,260,516 QoQ
Shares Held
438,812
+69.7% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#62
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Derivatives in SNY
reported options exposure · as of Dec 31, 2022CallValue
$0
CallShares
0
PutValue
$2,474,773
PutShares
51,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $6,106,168,968 across 18 Drug Manufacturers - General names. SNY ranks #13 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,199,053 | $1,438,180,257 | |
| 2 | JNJ |
Johnson & Johnson
|
3,925,186 | $996,879,486 | |
| 3 | AZN |
Astrazeneca PLC
|
4,895,753 | $928,332,681 | |
| 4 | ABBV |
AbbVie Inc.
|
2,327,207 | $585,618,368 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,614,905 | $464,515,291 | |
| 6 | PFE |
Pfizer Inc
|
19,228,115 | $463,013,007 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,969,159 | $375,123,546 | |
| 8 | AMGN |
Amgen Inc
|
1,020,869 | $369,677,081 |
All Filings in SNY
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,719,718 | 438,812 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $12,459,202 | 258,597 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,915,469 | 80,798 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $11,434,339 | 242,253 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $22,640,431 | 468,649 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $41,941,788 | 756,253 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $27,786,555 | 576,126 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $36,403,255 | 631,672 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $29,904,038 | 616,324 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $28,897,607 | 594,601 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $26,372,413 | 530,312 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $27,282,054 | 508,614 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $29,252,876 | 542,725 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $62,828,539 | 1,154,512 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $2,474,773 | 51,100 | Put | Defined | 2023-02-09 | |
| 2022-12-31 | $26,429,846 | 545,733 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $4,433,132 | 116,600 | Call | Defined | 2022-11-10 | |
| 2022-09-30 | $28,519,560 | 750,120 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $36,706,157 | 733,683 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $4,677,074 | 91,100 | Call | Defined | 2022-05-12 | |
| 2022-03-31 | $20,414,219 | 397,628 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $19,762,845 | 394,468 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $19,250,685 | 399,309 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $27,182,035 | 516,180 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $21,737,024 | 439,487 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $20,419,702 | 420,245 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $29,567,888 | 589,354 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $17,852,745 | 349,711 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $16,796,915 | 384,193 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||